Knockoff weight loss drugs are having a moment. Eli Lilly isn't worried
Bitcoin
In This Story LLY -7.85% NVO +0.64% Eli Lilly ( LLY -7.85% ) CEO David Ricks said the sale of cheaper, off-brand versions of the company’s blockbuster weight loss drug isn’t having a “financial impact” on the pharma giant. Suggested Reading Election betting site Polymarket has been giving Trump good odds. But it also might have a big fraud problem Google parent Alphabet reported revenues of $88.3 billion for the third quarter Google stock jumps 4% after AI momentum drives earnings Bitcoin's
din zilele anterioare